ALPHAMAB-B (09966) announced on October 24, 2025, that the company has resolved under its restricted share reward plan to grant a total of 1.9902 million reward shares to three eligible participants, including Dr. Xu Ting (Chairman and Executive Director), Ms. Liu Yang (Executive Director), and one employee of the group. The shares are to be issued for the subscription of up to a total of 1.9902 million common shares with a par value of $0.000002 each, subject to acceptance by the rewarded directors and employees.